Metabolic Bone Diseases, Molecular Cellular and Genetic Determinants of Bone Structure and Formation, Integrative Physiology of the Skeleton
Skeletal Consequences of Vitamin D Insufficiency/Deficiency (Calcium Homeostasis and Growth/Development)
Connie Weaver, Ph.D., Purdue University, West Lafayette, Indiana, USA
Treatment Strategies for Vitamin D (D3 vs. D2) Insufficiency/Deficiency in Diseases Including GI Disorders
Daniel D. Bikle, M.D., Ph.D., University of California Veterans Affairs Medical Center, San Francisco, California, USA
Vitamin D Insufficiency/Deficiency Contributions to the Morbidity of Patients With Osteoporosis
Neil Binkley, M.D., University of Wisconsin, Madison, Wisconsin, USA
Evidence Report on Vitamin D
Ann B. Cranney, MD, MSc, Ottawa Health Research Institute, Ottawa, Ontario, Canada
Supported by educational grants from Eli Lilly and Company, Merck & Co., Inc., NPS Pharmaceuticals, The Alliance for Better Bone Health (Procter & Gamble Pharmaceuticals and sanofi-aventis, US) and Immunodiagnostic Systems.
Funding for this conference was made possible (in part) by Grant AR055036 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute on Aging, National Institute of Diabetes and Digestive and Kidney Diseases and the Office of Dietary Supplements. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Length: 75 minutes